A nonradioactive dot blot hybridization assay for human parvovirus B19 DNA was set up by using a biotin-labeled DNA probe and streptavidin-alkaline phosphatase conjugate. The assay was used to examine 4,895 specimens referred for B19 virus diagnosis during 1987. Of 48 specimens that gave positive reactions for B19 DNA, 41 were confirmed virus positive by electron microscopy (n = 36), radioimmunoassay (n = 26), or counterimmunoelectrophoresis (n = 20 CIE (8). All sera were also tested for anti-B19 IgM by RIA (9), and selected sera were tested for anti-B19 IgG by RIA (9). Dot blot hybridization assay. (i) Specimen preparation. Portions (10 ,ul) of samples were mixed with 90 ,ul of 2x SSC (lx SSC is 0.15 M sodium chloride and 0.015 M sodium citrate, pH 7.0) and 100 ,ul of 1 M NaOH-2 M NaCl and incubated for 10 min at room temperature. The samples were then applied to nitrocellulose filters (102 by 133 mm) by using a Minifold apparatus (Schleicher & Schuell, Inc.) (iii) Prehybridization. Usually two filters, placed back to back, were sealed in polypropylene bags with 10 ml of a prehybridization mixture containing 5x SSC, 50% formamide, 25 mM NaPO4 (pH 6.5), S x Denhardt solution, and 250 ,ug of sheared denatured salmon sperm DNA per ml. The filters were incubated at 42°C for 2 to 4 h in a shaking water bath.
Human parvovirus B19 (B19 virus) was first detected in 1975 in the serum of healthy blood donors (10) .)It was later found to be the cause of aplastic crises in patients with sickle cell anemia (16) and other chronic hemolytic anemias (23) and of erythema infectiosum (fifth disease) in those with normal erythrocytes (3) . When adults are infected, particularly females, they often develop acute arthritis (22) . Another complication in this group is the risk of an unfavorable outcome to pregnancy should infection of the fetus occur (6) .
B19 infection is most often diagnosed by demonstrating a specific immunoglobulin M (IgM) response in sera taken shortly after onset of illness (2, 9) . It is less commonly diagnosed by detecting B19 virus, because viremia is usually transient and often precedes symptoms. The virus has been grown only in vitro in cultures of bone marrow enriched with erythroid cells (15) . This technique is not applicable to the routine detection of B19 virus in clinical samples, and biophysical methods are used instead. These include electron microscopy (EM) for parvovirus particles and radioimmunoassay (RIA) and counterimmunoelectrophoresis (CIE) for B19 antigen. The introduction of hybridization assays for B19 DNA, with probes incorporating 32P as a radioactive label, has provided a further, more sensitive means of detecting B19 virus in clinical specimens (4, 7) .
Recently, Cunningham et al. (11) have described a nonradioactive hybridization assay for B19 DNA using biotinylated RNA probes. We now describe our experience with a similar assay using DNA probes. The assay was done on all specimens submitted to our laboratory for B19 testing during 1987. It was compared with EM, RIA, and CIE for virus detection and with specific IgM serology for diagnosis of B19 infection. The advantages and shortcomings of this nonradioactive system are discussed.
MATERIALS AND METHODS
Specimens examined. A B19 antigen by RIA (9) and CIE (8) . All sera were also tested for anti-B19 IgM by RIA (9) , and selected sera were tested for anti-B19 IgG by RIA (9 The mixture was diluted with 3.0 ml of phosphate-buffered saline and centrifuged at 38,000 x g for 1 h. The pellet was drained and then suspended in 20 ,ul of distilled water, and 5 ,ul of the suspension was mixed with 5 il of 3% phosphotungstic acid, pH 6.5. The mixture was applied to a Formvarcarbon-coated grid, and the excess was removed by blotting.
Grids were examined with an electron microscope at a screen magnification of x60,000 for at least 20 min. If no virus particles were seen, three additional areas of the grid were examined at x6,000 on the screen and by using lOx binoculars to check for the presence of bacteria. This last procedure occasionally also revealed aggregates of virus particles which were present in such low concentration that they had been missed in the high-magnification examination of a necessarily small area of the grid.
(ii) Direct EM. The direct EM procedure was the same as the immune EM procedure described above but omitted the addition of a B19 antibody-containing serum. Examination of the grids was carried out at x60,000 magnification and was directed primarily towards detection of individual rather than aggregated parvovirus particles.
RESULTS
Positive dot blot reactions. A total of 48 specimens gave reactions in the dot blot hybridization assay that were stronger than that of the 100-pg B19 DNA control (Fig. 1) (Table 2 ). In three cases with serological follow-up, anti-B19 IgM rose to high levels. A fourth case followed up was that of a patient who had persistent B19 infection with fluctuating viremia (12) . There was no follow-up in three cases: that of a patient with sickle cell anemia involved in a family outbreak of aplastic crises; that of a child with leukemia and erythroid aplasia; and a case without clinical or epidemiological information or sufficient material for Southern blotting to be done. In three specimens the specificity of the DNA reaction was confirmed by Southern blotting (Table 2) .
Weakly positive dot blot reactions. A total of 81 specimens gave reactions in the dot blot hybridization assay that were considered weakly positive, i.e., equal to or less than the reaction given by the 100-pg B19 DNA control but greater than that of the negative control. In 11 cases, there was serological or epidemiological evidence that these reactions In addition to the problem of nonspecific reactions (discussed below), one possible shortcoming of this method was a prozonelike effect seen with strongly positive samples (Fig.   1 ). This may be due to steric hindrance, since it was not observed when probe DNA was labeled with 32P, a moiety much smaller than biotin (results not shown). Whatever its origins, this effect reduced the confidence with which definite and weak positive reactions could be distinguished. Apart from testing 70 serum samples which gave falsepositive reactions, we made no attempt to compare biotin labeling with 32p labeling. In most studies in which this has been done, 32P has been shown to be more sensitive than biotin (17) , often by testing dilutions of known positive material (21) . While recognizing that the additional sensitivity of 32P labeling is valuable for some applications (mainly research), we would argue that because the titer of B19 virus in clinical samples is usually high, biotinylated probes are sufficiently sensitive for diagnostic work.
We did not use nylon filters routinely, because in initial tests we found an unacceptable level of background coloration despite having followed the blocking procedure recommended by the manufacturers of the SA-AP conjugate (Bethesda Research Laboratories). High background levels sometimes develop with nitrocellulose filters when riboprobes for B19 virus (11) are used, but we did not find this a problem with DNA probes. It was also reported that the SA-AP conjugate supplied by Amersham International Plc was superior to that from other manufacturers (11). We did not investigate conjugates other than that made by Bethesda Research Laboratories.
Biotinylated probes have recently been used to detect B19 virus in fetal tissues by in situ hybridization (5, 18) .
Although this study did not include a rigorous comparison of test methods, it is clear that the hybridization assay detected more samples with B19 virus than the other techniques used. The additional diagnostic yield was at least 7 ( Table 2 ) and probably a further 11 (Table 3) samples. This was a third more than the yield by EM, the next most sensitive method.
In our hands, the least sensitive assays for B19 virus were RIA and CIE for viral antigen. It has previously been suggested that the presence of specific antibody may block the detection of B19 antigen in serum by these techniques (4, 9) . Our findings did not support this suggestion, because the detection rate for B19 antigen was not significantly different when antibody was present (15 of 21 tested by RIA) or absent (11 of 17 tested by RIA) ( Table 5 ).
In spite of the enhanced sensitivity provided by the dot blot hybridization assay, the diagnostic yield from anti-B19 IgM testing (n = 505) was approximately 10-fold greater than that from virus detection (n = 48). This is because viremia often precedes symptoms, whereas IgM is present at the onset of the rash, when a specimen is usually taken. The presence of anti-B19 IgM, sometimes in trace amounts, aided the interpretation of weak reactions in the hybridization assay.
Even though we used a viral probe that had been purified from vector DNA, we obtained many false-positive reactions. These reactions were usually weak, less than that given by the 100-pg B19 control (Fig. 1) . However, not all weak reactions were nonspecific, because some were obtained with samples thought to contain B19 virus (Table 3) .
Attempts to reduce nonspecific reactions by treating filters with proteinase K and with high-stringency washes were not successful.
Bacterial contamination was observed in 13 of 16 samples giving false-positive reactions that were examined by EM. We demonstrated bacterial and plasmid DNA in one contaminated sample (Fig. 2) and in a few samples which also contained B19 DNA (results not shown). This raised the possibility that vector homology (1) was a cause of nonspecificity. However, it is unlikely to be a common cause; although 62 samples giving false-positive reactions reacted with biotinylated vector DNA, only 7 reacted when the same DNA was labeled with 32P.
These findings, on the other hand, implicate the biotinavidin detection system as a common source of nonspecific reactions. In experiments in which specimens giving falsepositive reactions were simply bound to filters, reactions with the SA-AP conjugate were frequent. This suggests that some specimens contain biotin (or avidin-binding activity). The phenomenon has been found previously with other tissues by in situ hybridization (14) 
